Pharmaceuticals

Experience Highlights

• AstraZeneca as national counsel in multidistrict litigation involving proton pump inhibitors, Prilosec^® and Nexium^®.
• Auxilium Pharmaceuticals, now Endo Pharmaceuticals, in obtaining jury verdict in bellwether trial for multidistrict litigation involving testosterone replacement therapy. Holtsclaw v. Auxilium
• Bayer as national counsel in defending its oral anticoagulant prescription medicine, Xarelto^®. The cases were coordinated in an MDL proceeding, as well as coordinated state court proceedings. Based on our successful record of judgments, the companies agreed to a favorable settlement.
• Bristol-Myers Squibb and Sanofi in ending 12 years of litigation regarding their blood thinner drug, Plavix^®, without a single trial or settlement payment. The litigation spurred the US Supreme Court's review of critical specific jurisdiction issues and resulted in the landmark decision in BMS v. Superior Court of California.
• Bristol-Myers Squibb as national counsel and employed novel strategies that led to global settlement of litigation related to Abilify^®.
• Hologic and Cynosure in defeating class certification and obtaining summary judgment in a purported class action regarding the efficacy of the SculpSure device.
• Pfizer as coordinating science counsel, working with national counsel, for the science defense, securing two significant Daubert victories for the client. These victories led to a summary judgment ruling effectively ending the entire birth defect multi-district litigation for Zoloft^®.
• Pfizer, Pharmacia & Upjohn and Wyeth Pharmaceuticals as lead trial counsel, creating, coordinating and implementing the science defense and handling all phases of litigation for litigation related to several hormone therapy products.
• Sanofi as national counsel in product liability litigation involving the presence of the nitrosamine NDMA in the heartburn medication Zantac^®.